This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
4D Pharma : Lists on Nasdaq As Longevity Merger Closes, Raises $25 Million Via Share Placement MT
4D pharma plc completed the acquisition of Longevity Acquisition Corporation from Whale Management Corporation and others. CI
Longevity Acquisition Corporation(NasdaqCM:LOAC) dropped from NASDAQ Composite Index CI
Longevity Acquisition : Shareholders Approve Merger With 4D Pharma MT
4D Pharma : ADS Listing on Nasdaq Approved by US SEC MT
Longevity Acquisition Corporation Announces 4D Pharma plc Update on Oncology Program CI
Longevity Acquisition Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2020 CI
Longevity Acquisition : Regains Compliance With Nasdaq Listing Rules MT
Longevity Acquisition : 4D Pharma Files for SEC Registration, in Process to Gain NASDAQ Listing MT
Longevity Acquisition : Extends Proposed Deal Completion to May MT
Longevity Acquisition Corporation Announces Management Changes CI
Longevity Acquisition Corporation Announces Executive Changes CI
Longevity Acquisition Corporation Announces Board Changes CI
Longevity Acquisition Corporation Reports Earnings Results for the Second Quarter Ended August 31, 2020 CI
4D pharma plc signed a non-binding letter of intent to acquire Longevity Acquisition Corporation from Whale Management Corporation and others for $50.4 million. CI
Longevity Acquisition Corporation Reports Earnings Results for the First Quarter Ended May 31, 2020 CI
Longevity Acquisition Corporation Reports Earnings Results for the Full Year Ended February 29, 2020 CI
Longevity Acquisition Corporation announced that it has received $0.4 million in funding from Whale Management Corporation CI
Longevity Acquisition Corporation Announces Board Changes CI
Longevity Acquisition Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2019 CI
Longevity Acquisition Corporation Announces Board Changes CI
Longevity Acquisition Corporation Reports Earnings Results for the Second Quarter Ended August 31, 2019 CI
Longevity Acquisition Corporation Reports Earnings Results for the First Quarter Ended May 31, 2019 CI
Longevity Acquisition Corporation Reports Earnings Results for the Full Year Ended February 28, 2019 CI
Longevity Acquisition Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2018 CI
Chart Longevity Acquisition Corporation
More charts
Longevity Acquisition Corporation is a China-based blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation. The Company purchases all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. LOAC Stock
  4. News Longevity Acquisition Corporation
  5. Longevity Acquisition : Shareholders Approve Merger With 4D Pharma